Newsfeeds - Spark Newswire

1 minute read

News

Maryland Online Sports Betting December 2022 By Operator – Handle – % Of Handle: Fanduel- $236.2M – 49.4% Draftkings – $157.9M – 33% Betmgm – $42.3M – 8.9% Barstool- $16.4M – 3.4% Caesars- $15.6M – 3.3% Pointsbet – $6.7M – 1.4% Betriver- $3.2M – 0.7%

By Benzinga Newsdesk

Today, 12:19 PM

https://twitter.com/ButlerBets/status/1612853582650380302

BYD

1 minute read

Legal
News

Sports Betting Legislator Ryan Butler Tweets ‘Maryland Recorded Nearly $500M In Sports Betting Handle In December, Its First Full Month With Legal Mobile Wagering, The Vast Majority Of That Coming Online, According To A Release From Regulators Today’

By Benzinga Newsdesk

Today, 12:19 PM

https://twitter.com/ButlerBets/status/1612851527299002369

BYD

5 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 12:19 PM

On Monday, 79 companies reached new 52-week lows.

ADCT

1 minute read

Rocket Lab, Lufax Holding And 3 Stocks To Watch Heading Into Friday

By Lisa Levin

Today, 12:19 PM

With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:

GAN

1 minute read

GAN Announces Departure of Chief Financial Officer; Search Process for Next Chief Financial Officer Underway; Appointed Mr. Brian Chang, Senior Vice President, Corporate Controller, To Assume The Duties Of Chief Financial Officer In The Interim

By Benzinga Newsdesk

Today, 12:19 PM

Search Process for Next Chief Financial Officer Underway GAN Limited (NASDAQ:GAN) (the "Company" or "GAN"), a leading North American B2B technology provider of real money internet gaming solutions

GAN

8 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 12:19 PM

OnThursday, 137 stocks made new 52-week lows.

AAP

1 minute read

Jefferies Downgrades GAN to Hold, Announces $2 Price Target

By Benzinga Newsdesk

Today, 12:19 PM

Jefferies analyst David Katz downgrades GAN (NASDAQ:GAN) from Buy to Hold and announces $2 price target.

GAN

17 minute read

Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights

Today, 12:19 PM

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC